1. Home
  2. RAPP vs DGICA Comparison

RAPP vs DGICA Comparison

Compare RAPP & DGICA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPP
  • DGICA
  • Stock Information
  • Founded
  • RAPP 2022
  • DGICA 1986
  • Country
  • RAPP United States
  • DGICA United States
  • Employees
  • RAPP N/A
  • DGICA N/A
  • Industry
  • RAPP
  • DGICA Property-Casualty Insurers
  • Sector
  • RAPP
  • DGICA Finance
  • Exchange
  • RAPP Nasdaq
  • DGICA Nasdaq
  • Market Cap
  • RAPP 463.8M
  • DGICA 510.1M
  • IPO Year
  • RAPP 2024
  • DGICA N/A
  • Fundamental
  • Price
  • RAPP $11.04
  • DGICA $16.99
  • Analyst Decision
  • RAPP Strong Buy
  • DGICA
  • Analyst Count
  • RAPP 4
  • DGICA 0
  • Target Price
  • RAPP $37.33
  • DGICA N/A
  • AVG Volume (30 Days)
  • RAPP 124.0K
  • DGICA 91.7K
  • Earning Date
  • RAPP 03-07-2025
  • DGICA 02-20-2025
  • Dividend Yield
  • RAPP N/A
  • DGICA 4.15%
  • EPS Growth
  • RAPP N/A
  • DGICA 1022.92
  • EPS
  • RAPP N/A
  • DGICA 1.50
  • Revenue
  • RAPP N/A
  • DGICA $989,605,000.00
  • Revenue This Year
  • RAPP N/A
  • DGICA N/A
  • Revenue Next Year
  • RAPP N/A
  • DGICA $7.69
  • P/E Ratio
  • RAPP N/A
  • DGICA $11.05
  • Revenue Growth
  • RAPP N/A
  • DGICA 6.71
  • 52 Week Low
  • RAPP $11.02
  • DGICA $12.26
  • 52 Week High
  • RAPP $29.74
  • DGICA $17.00
  • Technical
  • Relative Strength Index (RSI)
  • RAPP N/A
  • DGICA 79.96
  • Support Level
  • RAPP N/A
  • DGICA $15.26
  • Resistance Level
  • RAPP N/A
  • DGICA $15.96
  • Average True Range (ATR)
  • RAPP 0.00
  • DGICA 0.47
  • MACD
  • RAPP 0.00
  • DGICA 0.20
  • Stochastic Oscillator
  • RAPP 0.00
  • DGICA 99.53

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

About DGICA Donegal Group Inc.

Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.

Share on Social Networks: